Is sepsis accurately coded on hospital bills?

PubWeight™: 1.60‹?› | Rank: Top 4%

🔗 View Article (PMID 11918823)

Published in Value Health on March 28, 2002

Authors

Daniel A Ollendorf1, A Mark Fendrick, Karen Massey, G Rhys Williams, Gerry Oster

Author Affiliations

1: Policy Analysis Inc., Brookline, Massachusetts 02445, USA.

Articles citing this

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis (2007) 6.75

Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med (2007) 3.17

Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis (2005) 3.09

Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med (2011) 2.45

Epidemiology of severe sepsis. Virulence (2013) 2.26

The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med (2006) 2.21

Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol (2011) 1.83

National variation in United States sepsis mortality: a descriptive study. Int J Health Geogr (2010) 1.53

Validity of administrative data in recording sepsis: a systematic review. Crit Care (2015) 1.21

TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis. Medicine (Baltimore) (2011) 1.09

Quantifying the improvement in sepsis diagnosis, documentation, and coding: the marginal causal effect of year of hospitalization on sepsis diagnosis. Ann Epidemiol (2015) 0.90

Accuracy of administrative data for surveillance of healthcare-associated infections: a systematic review. BMJ Open (2015) 0.89

Staphylococcal infections in children, California, USA, 1985-2009. Emerg Infect Dis (2013) 0.82

Long term outcomes following hospital admission for sepsis using relative survival analysis: a prospective cohort study of 1,092 patients with 5 year follow up. PLoS One (2014) 0.81

Risk and Prognosis of Bloodstream Infections among Patients on Chronic Hemodialysis: A Population-Based Cohort Study. PLoS One (2015) 0.80

Use of the International Classification of Diseases, 9th revision, coding in identifying chronic hepatitis B virus infection in health system data: implications for national surveillance. J Am Med Inform Assoc (2013) 0.79

Validation and optimisation of an ICD-10-coded case definition for sepsis using administrative health data. BMJ Open (2015) 0.78

Low Completeness of Bacteraemia Registration in the Danish National Patient Registry. PLoS One (2015) 0.77

Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO. Medicine (Baltimore) (2017) 0.75

The impact of septicemia occurring during hospitalization for renal transplantation procedures on outcomes in adults in United States. PLoS One (2017) 0.75

Articles by these authors

(truncated to the top 100)

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation (2004) 7.77

Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13

Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood) (2008) 6.13

Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 5.86

Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol (2003) 5.16

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med (2003) 4.67

What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med (2003) 3.88

The health effects of restricting prescription medication use because of cost. Med Care (2004) 3.65

The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med (2003) 3.32

Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med (2003) 3.30

Value-based insurance design. Health Aff (Millwood) (2007) 3.27

Health-related quality of life varies among obese subgroups. Obes Res (2002) 3.05

Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68

Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. Value Health (2003) 2.61

Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol (2003) 2.60

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med (2005) 2.60

Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis (2009) 2.41

Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39

Comparing local and regional variation in health care spending. N Engl J Med (2012) 2.30

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care (2003) 2.29

Therapy switching in patients receiving long-acting opioids. Ann Pharmacother (2004) 2.14

Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Value Health (2004) 2.05

Stroke risk after nonstroke emergency department dizziness presentations: a population-based cohort study. Ann Neurol (2014) 2.02

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med (2004) 2.01

Approval times for new drugs: does the source of funding for FDA staff matter? Health Aff (Millwood) (2004) 1.95

Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain (2004) 1.92

Out-of-pocket health-care expenditures among older Americans with cancer. Value Health (2004) 1.86

Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans. Alzheimer Dis Assoc Disord (2004) 1.85

Improving cancer screening adherence: using the "teachable moment" as a delivery setting for educational interventions. Am J Manag Care (2004) 1.84

Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med (2004) 1.76

Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr (2004) 1.69

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer (2006) 1.61

An integrated method to determine meaningful changes in health-related quality of life. J Clin Epidemiol (2004) 1.58

Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother (2011) 1.58

Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med (2008) 1.56

Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? Am J Manag Care (2005) 1.55

Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care (2009) 1.52

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology (2004) 1.49

Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest (2002) 1.49

Walking speed predicts health status and hospital costs for frail elderly male veterans. J Rehabil Res Dev (2005) 1.48

The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology (2004) 1.47

Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol (2008) 1.41

Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine (2009) 1.40

Opioid use and health care charges at the end of life in patients with metastatic cancer. Manag Care Interface (2004) 1.38

Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States. Am J Cardiol (2006) 1.35

Associations in breast and colon cancer screening behavior in women. Acad Radiol (2005) 1.32

Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer (2011) 1.30

Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology (2012) 1.29

Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol (2006) 1.28

Behavioral associations between prostate and colon cancer screening. J Am Coll Surg (2005) 1.28

Dizziness presentations in U.S. emergency departments, 1995-2004. Acad Emerg Med (2008) 1.27

Women's health and the Affordable Care Act: high hopes versus harsh realities? Am J Public Health (2014) 1.24

Extent and cost of informal caregiving for older Americans with symptoms of depression. Am J Psychiatry (2004) 1.24

Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? Clin Gastroenterol Hepatol (2004) 1.24

Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med (2008) 1.23

Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs. Am J Manag Care (2006) 1.22

Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22

Impact of weight loss and regain on quality of life: mirror image or differential effect? Obes Res (2003) 1.22

Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D. Value Health (2004) 1.20

Evidence that value-based insurance can be effective. Health Aff (Millwood) (2010) 1.17

Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Ann Pharmacother (2006) 1.15

Informal caregiving for diabetes and diabetic complications among elderly americans. J Gerontol B Psychol Sci Soc Sci (2002) 1.13

Payer type and the returns to bypass surgery: evidence from hospital entry behavior. J Health Econ (2002) 1.12

Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm (2006) 1.12

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther (2009) 1.10

Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens (2007) 1.10

Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience. Am J Manag Care (2003) 1.09

Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt) (2008) 1.09

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol (2003) 1.09

Barriers to constraining health care cost growth. Health Aff (Millwood) (2004) 1.07

Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06

Acute exacerbation of chronic bronchitis: a primary care consensus guideline. Am J Manag Care (2004) 1.06

Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? J Am Coll Radiol (2004) 1.06

Cost-utility of aspirin and proton pump inhibitors for primary prevention. Arch Intern Med (2011) 1.05

Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-directed health plans. J Gen Intern Med (2007) 1.05

The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value Health (2002) 1.04

The impact of out-of-pocket costs on the use of intrauterine contraception among women with employer-sponsored insurance. Med Care (2013) 1.03

Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02

Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol (2010) 1.02

Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited. J Gen Intern Med (2006) 1.02

Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol (2005) 1.01

Fast food franchises in hospitals. JAMA (2002) 1.01

Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res (2006) 1.01

Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease. Arch Intern Med (2002) 1.01

Effectiveness of bisphosphonate therapy in a community setting. Bone (2008) 1.01

Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol (2011) 1.00

Dose intensification with infliximab in patients with rheumatoid arthritis. Ann Pharmacother (2005) 1.00

Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. Am J Clin Oncol (2012) 0.99

Value-based insurance design in oncology. Lancet Oncol (2011) 0.99

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98

The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice. Arch Neurol (2011) 0.97

Summing the risk of NSAID therapy. Lancet (2007) 0.97

Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol (2009) 0.96

Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol (2007) 0.96

Out-of-pocket health care expenditures among older Americans with dementia. Alzheimer Dis Assoc Disord (2004) 0.96

Adherence with migraine prophylaxis in clinical practice. Pain Pract (2012) 0.95

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life. J Rheumatol (2006) 0.95

Nystagmus assessments documented by emergency physicians in acute dizziness presentations: a target for decision support? Acad Emerg Med (2011) 0.95

Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92

Defining cause of death in stroke patients: The Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol (2006) 0.92